MindMaze Therapeutics Appoints John W. Krakauer as Strategic Advisor

MindMaze Therapeutics Holding SA announced the appointment of Professor John W. Krakauer as a strategic advisor. Krakauer will support the company's next phase of development.

Krakauer, recognized for his work in neuroscience and neurology, brings extensive experience and expertise to the role. His responsibilities will include advising on strategic matters related to the development and expansion of MindMaze's neurotherapeutic solutions.

The company aims to strengthen its position in treating neurological disorders and to develop new, scalable therapies through this appointment.

MindMaze Therapeutics focuses on developing precision neurotherapeutics that leverage advanced technology for patient rehabilitation and the improvement of quality of life.